Bad GMO Labeling Bill Expected Soon

Bad GMO Labeling Bill Expected Soon

A new bill to let food producers decide whether to label GMOs could prevent states from passing mandatory labeling laws. It’s expected to be introduced in the next few weeks—so we need to dissuade potential co-sponsors now! Action Alert! At the behest of the Monsantos and Cargills of the world, Rep. Mike Pompeo (R-KS) is expected […]

Read More
GMO Roundup

GMO Roundup

The GMO labeling issue is seeing some action on Capitol Hill. Maybe that’s because GMOs are in the news across the country. Here are some of the stories you may have missed. Monsanto Settles with US Wheat Farmers Monsanto has settled class-action lawsuits with farmers in seven states over 2013 contamination from their genetically engineered “Roundup Ready” […]

Read More
NY Attorney General Doubles Down in His Supplement Attack

NY Attorney General Doubles Down in His Supplement Attack

Having made his initial move based on discredited tests, he is now broadening the offensive and pulling in AGs from other states. Action Alert! Early last month, New York Attorney General Eric Schneiderman sent cease-and-desist letters to four major national chain retailers, charging them with selling nutritional supplements that were “deliberately mislabeled” and “potentially dangerous to […]

Read More
Once Again, the FDA Deliberately Keeps Us in the Dark about Bad Science

Once Again, the FDA Deliberately Keeps Us in the Dark about Bad Science

It’s the same old story of prescription drugs and fraudulent studies, but the FDA doesn’t seem to care. Action Alert! A recent article in Slate magazine shows how the FDA hides important safety information when it uncovers scientific misconduct in clinical trials of pharmaceutical drugs. The names of the drugs and the company responsible for the misconduct are concealed, journal […]

Read More
FDA Compounding Committee Is a Stacked Deck

FDA Compounding Committee Is a Stacked Deck

Conflicts of interests and rampant biases on the committee advising FDA on the new compounding rules? Yes—in abundance! Related Action Alert! Last week, we wrote about the FDA’s latest efforts to regulate compounding pharmacies in its draft Memorandum of Understanding (MOU). Although these provisions are still in the process of being completed, it’s looking increasingly likely […]

Read More